Abstract:Key PointsCRISPR–Cas (clustered regularly interspaced short palindromic repeats–CRISPR-associated proteins) is an adaptive immune system in bacteria and archaea, which is categorized into three distinct types (known as type I, type II and type III) that differ in their compositions and mechanisms of action. Adaptive immunity occurs in three distinct stages: acquisition, expression and interference.In all three types of CRISPR–Cas system, spacer acquisition relies on a pair of conserved Cas proteins (Cas1 and Cas2), which are probably assisted by a variable set of additional (potentially both Cas and non-Cas) enzymes.Primary processing of CRISPR RNAs (crRNAs) is catalysed either by Cas6-like ribonucleases (in the type I and type III systems) or by RNase III (which targets the crRNA and transactivating crRNA (tracrRNA) duplex in type II systems).Mature crRNAs form CRISPR ribonucleoprotein (crRNP) complexes by associating with either Cascade-like multiprotein complexes (in type I and type III systems) or the multidomain Cas9 protein (in type II systems).Discrimination of 'self' nucleic acid from 'non-self' nucleic acid enables crRNP complexes to specifically target invading nucleic acid (usually DNA). Some complexes recruit additional nucleases (for example, Cas3 in type I systems), whereas other crRNPs have intrinsic nuclease domains (for example, Cas9 in type II systems).Fundamental studies have elucidated many mechanistic features of CRISPR–Cas functionality by integrating genetics, biochemistry and structural biology. This has provided an excellent basis for developing a wide range of applications, from the manipulation of gene expression in bacteria to genome editing in eukaryotes.

Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system

Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system

Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity

Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity

Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers

Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein

Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Structures of the CRISPR Genome Integration Complex

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Cas5d Protein Processes Pre-Crrna and Assembles into a Cascade-Like Interference Complex in Subtype I-C/Dvulg CRISPR-Cas System.

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Structure and mechanism of the type I-G CRISPR effector

Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria

Cas1-Cas2 physically and functionally interacts with DnaK to modulate CRISPR Adaptation

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

DNA Motifs and an Accessory CRISPR Factor Determine Cas1 Binding and Integration Activity in Sulfolobus Islandicus

The CRISPR effector Cam1 mediates membrane depolarization for phage defence